Re-operation for parotid gland cancer following non-standard surgical treatment  

腮腺癌不规范手术后再手术相关问题探讨(英文)

作　　者：Xiangmin Zhang Xiaolin Lan Lianbin Liu Rong Li Fufu Xiao Folin Liu 

机构地区：[1]Department of Head and Neck, Tumor Hospital of Ganzhou, Ganzhou 341000, China [2]The First Affiliated Hospital of Gannan Medical University, Ganzhou 341000, China

出　　处：《The Chinese-German Journal of Clinical Oncology》2012年第4期192-195,共4页中德临床肿瘤学杂志（英文版）

摘　　要：Objective:The purpose of this study was to analyze the clinical disadvantages of non-standard surgical treatment for parotid gland cancer and probe the re-operative indication following non-standard surgical treatment.Methods: Data of 58 cases suffered parotid gland cancer who received non-standard operation at other hospital and received re-operation in tumor hospital of Ganzhou from June 1998 to October 2010 were retrospectively reviewed.Results: In all cases,parotid gland cancer were residual in 46 cases,the facial nerve remaining rate was 81.0% (47/58),facial nerve branches injury rate was 3.5% (2/58),facial nerve partial resection rate was 8.6% (5/58) and total resection rate was 6.9% (4/58).The sensitivity of residual tumor was 83.3%,scanned by contrast-enhanced CT and the CT positive predictive value was 86.9%. Conclusion: Consideration of the higher residual tumor rate in patients who received non-standard operations,the re-operations were necessary.Contrast-enhanced CT positive predictive value was high for residual tumor and it was important for re-operation.

关 键 词：parotid gland neoplasms CARCINOMA RE-OPERATION 

分 类 号：TS207.3[轻工技术与工程—食品科学] TU246.187[轻工技术与工程—食品科学与工程]